Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190618043934N15Phase 3Completed
Phase 3, randomised, open-label trial in cataract comparing Melatonin with Midazolam (2 arms). Primary endpoints: Preoperative anxiety and Intraoperative hemodynamic disorders. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190618043934N15.